Lumentum Holdings Inc. (LITE) — Fundamental Analysis

Lumentum Holdings (LITE) is a photonics and optical products company that has been on a bumpy road over the past few years — revenue peaked around fiscal 2023, dipped sharply in fiscal 2024, and has begun recovering into fiscal 2025. The business is not yet reliably profitable on a net or operating basis, though fiscal 2025 marks a meaningful step forward: gross margins are climbing back toward 28%, the net margin has turned modestly positive for the first time in two years, and EBITDA has swung firmly back into positive territory. The balance sheet remains relatively liquid with a current ratio above 4x, though the company now carries meaningful debt. Capital spending has jumped sharply in fiscal 2025 — a sign that management is reinvesting heavily, likely in support of growing AI-related datacom demand — which is worth watching carefully given the still-thin profitability. In short, Lumentum looks like a company in early-stage recovery, with real tailwinds from optical connectivity in AI infrastructure, but profitability still has a long way to go before it reaches the levels seen in fiscal 2022.

Snapshot & Big Picture

Lumentum designs and manufactures optical and photonic products used in telecom networks, datacom infrastructure, and industrial and consumer applications. The company has been navigating a prolonged downturn in telecom spending while pivoting toward fast-growing datacom markets — particularly transceivers and components tied to AI data center buildouts. The four-year annual record below captures a company that was highly profitable in fiscal 2022, ran into significant headwinds in fiscal 2023 and 2024, and is now showing early signs of a genuine recovery in fiscal 2025.

Latest Quarter Snapshot

The most recent quarterly filing data was not available in the provided data feed (the quarterly data field returned null). However, two 10-Q filings have been filed with the SEC covering the quarters ended December 27, 2025 and March 28, 2026 — both of which post-date the fiscal year 2025 annual data above. Those filings are linked in the Source Filings section below and represent the most current financial picture available for Lumentum. Readers seeking the latest quarterly revenue, margins, and balance sheet figures should refer directly to those filings, as they are more current than all of the annual data discussed in this post.

Profitability

The profitability trend over four fiscal years tells a clear story of peak, collapse, and nascent recovery. In fiscal 2022, Lumentum was genuinely profitable — gross margins above 46%, operating margins near 18%, and a healthy net margin above 11%. That picture deteriorated sharply: by fiscal 2023 the gross margin had fallen to 32% and operating and net margins turned negative, suggesting mounting cost pressure even as revenue held up reasonably well. Fiscal 2024 was the trough — revenue fell to $1.36B, gross margin cratered to 18.5%, and the net margin hit -40%, a period that included significant impairments or restructuring charges. Fiscal 2025 shows a clear inflection: revenue rebounded to $1.645B, gross margin recovered to nearly 28%, EBITDA turned positive at $73.9M, and the net margin edged into positive territory at +1.57%. Operating margin remains negative at -10.95%, meaning below-the-line items (interest income, gains, or tax benefits) are helping net income more than operations alone — a reminder that the operating business is still in recovery mode and has not yet recaptured the efficiency of fiscal 2022.

Financial Health

Lumentum's liquidity position is solid. The current ratio has remained well above 4x across most of the period, sitting at 4.37x in fiscal 2025, and even reached nearly 5.9x at the fiscal 2024 year-end — suggesting the company maintained a large cash buffer even through its most difficult year. That said, the debt picture has changed materially. Debt-to-equity data was not available in the SEC filings for fiscal 2022 or fiscal 2023, but by fiscal 2024 the ratio stood at 2.61x and improved modestly to 2.27x in fiscal 2025. This level of leverage is meaningful, particularly for a company still producing negative operating margins, and warrants monitoring as the recovery continues.

Capital expenditures tell an important story about Lumentum's reinvestment cycle. Spending was relatively contained through fiscal 2022–2024:

The jump in fiscal 2025 is striking — CapEx nearly doubled year-over-year in dollar terms, rising from $133M to $231M, and as a share of revenue it climbed from roughly 10% to 14%. This is a significant increase in capital intensity for a business that is not yet generating positive operating income. It likely reflects aggressive investment in manufacturing capacity and next-generation product lines to capture AI-driven datacom demand. While this reinvestment could pay off handsomely if demand materializes, it also pressures free cash flow in the near term and raises the stakes on the revenue recovery continuing.

Growth

The three-year revenue CAGR of -1.33% reflects the fact that Lumentum's revenue in fiscal 2025 is almost exactly where it was three years ago in fiscal 2022, having taken a round-trip through a painful trough in between. The five- and ten-year CAGR figures are not available because the dataset does not extend back far enough to compute those windows. The flat three-year growth rate underscores that Lumentum is fundamentally a recovery story right now rather than a high-growth compounder — the near-term thesis rests on margin expansion and share gains in AI datacom, not on headline revenue growth alone.

Source Filings

• Form 10-Q — Filed May 6, 2026 (Quarter ended March 28, 2026)
• Form 10-Q — Filed February 4, 2026 (Quarter ended December 27, 2025)